First use of CRISPR against cancer in patients clears safety hurdles

First use of CRISPR against cancer in patients clears safety hurdles

First use of CRISPR against cancer in patients clears early safety hurdles

By ASSOCIATED PRESS

ADOBE

In a small, early trial, doctors were able to take immune system cells from the patients' blood and alter them to help them recognize and fight cancer.

READ MORE